Drug · DIN 02385953
RANITIDINE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 19, 2022; first marketed June 11, 2012.
- Drug Identification Number (DIN)
- 02385953
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ranitidine A02BA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANITIDINE (RANITIDINE HYDROCHLORIDE) | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 23, 2018: NOC 20777New Drug Submission (NDS) · Licensing agreement between two companies
- June 8, 2012: NOC 13376Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named RANITIDINE
- DIN 00740748 · Cancelled Post Market
- DIN 00740756 · Cancelled Post Market
- DIN 02245615 · Cancelled Pre Market
- DIN 02286106 · Cancelled Post Market
- DIN 02286114 · Cancelled Post Market
- DIN 02303353 · Cancelled Post Market
- DIN 02303388 · Cancelled Post Market
- DIN 02343436 · Cancelled Pre Market
- DIN 02343444 · Cancelled Pre Market
- DIN 02353016 · Dormant
- DIN 02353024 · Dormant
- DIN 02385961 · Cancelled Post Market